PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Pascale Willem

The Coding Genome Of HIV-Associated Plasmablastic Lymphomas In South Africa

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Hodgkin lymphoma Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Smita Bhatia

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction

Hodgkin lymphoma Breast

Radiation Oncology Pediatric oncology or childhood cancer

Edward R Kastenhuber

Intratumoral Heterogeneity and Tumor Evolution in Lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Alberto Martin

The mechanisms of secondary antibody diversification processes

Non-Hodgkin lymphoma Hodgkin lymphoma

Tim Greten

Immune Suppressor Mechanism Analysis in Patients with Hepatocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology

Nathaniel Rothman

International Lymphoma Epidemiology Consortium (InterLymph)

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma Kaposi sarcoma Hodgkin lymphoma

Pathology